Latest 3B (3rd June) shows 86m shares on issue (excluding performance shares & unlisted options) They raised 6m in April from the relisting EV is tiny ... Lots of leverage from this price point
PTX This rare type of lymphoma ruins the body – so do existing treatments. Prescient could have a solution